tiprankstipranks
Check Point Software Technologies Q2 Results Top Estimates; Shares Fall 3.8%
Market News

Check Point Software Technologies Q2 Results Top Estimates; Shares Fall 3.8%

Cybersecurity solutions provider Check Point Software Technologies Ltd. (CHKP) has reported better-than-expected results for the second quarter of 2021. The strong results were primarily driven by the growth witnessed in revenues.

Following the earnings, shares of the company declined 3.8% to close at $121.10 in Monday’s trading session.

The company reported quarterly earnings per share (EPS) of $1.61, up 2% from last year, surpassing the consensus estimate of $1.56.

The company reported quarterly revenues of $526.1 million, which denotes a growth of about 4.1% from last year. Further, it topped the consensus estimate of $523.8 million. This rise can be attributed primarily to the growth witnessed in the revenues generated from Security subscriptions.

The CEO of Check Point Software Technologies, Gil Shwed, said “We had a good second quarter. Strong execution drove double-digit growth across CloudGuard and Harmony, and triple-digit growth in Infinity platform sales. Overall we grew our security subscription revenues by 12%.” (See Check Point Software Technologies stock chart on TipRanks)

On July 26, Cowen & Co. analyst Shaul Eyal reiterated a Buy rating on the stock. The analyst, however, raised the price target from $140 to $142, which implies upside potential of 17.3% from current levels.

The Wall Street community is cautiously optimistic about the stock with a Moderate Buy consensus based on 3 Buys, 3 Holds and 1 Sell. The average Check Point Software Technologies price target of $136.67 implies 12.9% upside potential from current levels.

Check Point Software Technologies scores a 9 out of 10 on TipRanks’ Smart Score rating system, indicating that the stock has strong potential to outperform market expectations. Shares have declined 2.3% over the past year.

Related News:
Meridian to Acquire Otsuka’s North American BreathTek Business for $20M
Lumen Expands Fiber Network Infrastructure in Europe
Cortexyme Develops 3CLpro Inhibitor to Treat COVID-19 Infection

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles